- Home
- GLPI vs UTHR Comparison
GLPI vs UTHR Comparison
Compare GLPI & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPI
- UTHR
- Stock Information
- Founded
- GLPI 2013
- UTHR 1996
- Country
- GLPI United States
- UTHR United States
- Employees
- GLPI N/A
- UTHR N/A
- Industry
- GLPI Real Estate Investment Trusts
- UTHR Biotechnology: Pharmaceutical Preparations
- Sector
- GLPI Real Estate
- UTHR Health Care
- Exchange
- GLPI Nasdaq
- UTHR Nasdaq
- Market Cap
- GLPI 13.5B
- UTHR 13.8B
- IPO Year
- GLPI N/A
- UTHR 1999
- Fundamental
- Price
- GLPI $47.38
- UTHR $403.68
- Analyst Decision
- GLPI Buy
- UTHR Strong Buy
- Analyst Count
- GLPI 13
- UTHR 15
- Target Price
- GLPI $52.33
- UTHR $449.13
- AVG Volume (30 Days)
- GLPI 2.0M
- UTHR 884.7K
- Earning Date
- GLPI 10-23-2025
- UTHR 10-29-2025
- Dividend Yield
- GLPI 6.57%
- UTHR N/A
- EPS Growth
- GLPI N/A
- UTHR 17.94
- EPS
- GLPI 2.61
- UTHR 25.63
- Revenue
- GLPI $1,565,067,000.00
- UTHR $3,077,800,000.00
- Revenue This Year
- GLPI $5.71
- UTHR $13.89
- Revenue Next Year
- GLPI $3.34
- UTHR $5.68
- P/E Ratio
- GLPI $18.22
- UTHR $15.74
- Revenue Growth
- GLPI 5.38
- UTHR 17.62
- 52 Week Low
- GLPI $44.48
- UTHR $266.98
- 52 Week High
- GLPI $52.27
- UTHR $436.95
- Technical
- Relative Strength Index (RSI)
- GLPI 47.94
- UTHR 68.95
- Support Level
- GLPI $47.13
- UTHR $396.12
- Resistance Level
- GLPI $48.44
- UTHR $407.06
- Average True Range (ATR)
- GLPI 0.61
- UTHR 13.53
- MACD
- GLPI -0.11
- UTHR 2.19
- Stochastic Oscillator
- GLPI 15.93
- UTHR 75.31
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.